KPT-330
13-563
Phase 1 small_molecule active
Quick answer
KPT-330 for Relapsed Acute Lymphoblastic Leukemia (ALL) is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Relapsed Acute Lymphoblastic Leukemia (ALL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active